---
schema_version: "secwatch.filing_event.v1"
accession: "0001649094-25-000102"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2025-09-30T23:59:59+00:00"
generated_at: "2026-05-17T05:16:01.753661+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte signs 15-year manufacturing deal with Thermo Fisher's Patheon

## Summary
- Agreement covers formulation, fill, finish, testing at Patheon's Greenville, NC facility.
- Binding minimum purchase commitments; termination fee in mid-eight-figures for convenience.
- Initial 15-year term with auto-renewal; includes tech transfer and capex reimbursement.
- Customary termination rights for cause, regulatory breach, or insolvency.

## SEC filing metadata
- accession: 0001649094-25-000102
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2025-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/0001649094-25-000102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000102/pcvx-20250924.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001649094-25-000102
- JSON: https://secwatch.observer/filing/0001649094-25-000102.json
- Plain text: https://secwatch.observer/filing/0001649094-25-000102.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.